Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy.
“The Zika virus is transmitted by the tiger mosquito. Roughly twenty percent of the people who are infected actually get sick,” explains Professor Neyts. “The most common symptoms, which last about a week, are fever, fatigue, joint and muscle pain, rash, and red eyes. A small number of infected people go on to develop Guillain-Barré Syndrome, which causes muscle weakness and temporary paralysis. In some cases, the patient needs to be put on a ventilator.”
http://labmol.redirectme.net/zika/wp-content/uploads/sites/5/2016/05/115660_web-1.jpg 480 720 melina http://labmol.redirectme.net/zika/wp-content/uploads/sites/5/2016/05/openika-novo-1-300x227.png melina2016-05-18 13:11:032016-05-18 13:11:03Experimental drug against hepatitis C slows down Zika virus infection in mice